Compare Tractor Supply Co (TSCO) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tractor Supply Co vs Zimmer Biomet Holdings Inc — how do they compare? Tractor Supply Co trades at $33.7 (market cap $17.44B), while Zimmer Biomet Holdings Inc trades at $89.14 (market cap $16.95B). The key difference: Tractor Supply Co and Zimmer Biomet Holdings Inc are close in size by market cap, and Tractor Supply Co pays the higher dividend (2.87%). Which is the better fit depends on your goals — on Pluang, investors hold Tractor Supply Co for 89 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| TSCO | ZBH | |
|---|---|---|
Market Cap | $17.44B | $16.95B |
Volume | 10,598,723 | 2,505,240 |
Sector | Consumer Cyclical | Health |
52-Week High | $56.37 | $103.98 |
52-Week Low | $29.14 | $79.58 |
Typical Hold Time | 89 Days | 89 Days |
Enterprise Value | $23.76B | $24.02B |
Dividend Yield | 2.87% | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Tractor Supply (TSCO) trades at $33.48, up 2.95% on the day, with a bullish technical signal from moving averages despite mixed oscillators. The company reported three consecutive quarterly earnings misses but maintains strong profitability with a 36.46% gross margin and 39.51% ROE. Recent news highlights expansion with a new Idaho distribution center and ongoing community initiatives, though concerns about dividend sustainability persist amid earnings pressure.
The outlook is cautiously optimistic with a consensus price target of $36.76 offering ~10% upside, supported by solid fundamentals and a 17-year dividend growth streak. Key risks include competitive pressures, execution challenges from recent misses, and economic sensitivity. Institutional sentiment is mixed with some trimming positions, but analyst consensus leans slightly bullish with 48% buy ratings.
Zimmer Biomet (ZBH) trades at $88.91, up 0.47% today, with a bearish technical signal from moving averages. The company reported Q2 2026 EPS of $2.07, beating estimates, and raised its 2026 outlook. Revenue growth remains steady, with 2025 revenue at $8.23B, though net income margin declined to 8.56%. The stock is supported by a quarterly dividend of $0.24 and a consensus price target of $103.11, suggesting potential upside.
The outlook is mixed: strong fundamentals and analyst optimism contrast with technical weakness. Investment opportunities include consistent earnings beats and dividend income, but risks involve rising debt levels and competitive pressures in the medical technology sector. The stock's current valuation at a P/E of 21.57 appears reasonable if growth continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tractor Supply Co
Tractor Supply is the largest operator of retail farm and ranch stores in the United States. The company targets recreational farmers and ranchers and has little exposure to commercial and industrial farm operations. Currently, the company operates 2,016 of its namesake banners in 49 states and 178 Petsense stores. Stores are typically located in towns outside of urban areas and in rural communities. In fiscal 2021, revenue consisted primarily of livestock and pet (47%), hardware, tools, and truck (21%), and seasonal gift and toy (21%).
Read more on TSCO →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
